Cargando…
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is a highly aggressive subtype of breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy. Although its prevalence among newly diagnosed breast cancers is approximately 12.7%, it accounts for 40% of breast cancer-rela...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345029/ https://www.ncbi.nlm.nih.gov/pubmed/34359598 http://dx.doi.org/10.3390/cancers13153697 |